We will be born again as a global pharmaceutical company through innovative drug development
Advancing toward a Global Pharmaceutical Company
Samjin Research Institute
plans to expand and transfer the institute to Magok area, Seoul in 2021 in order to strengthen its R&D infrastructure and expand its state-of-the-art research facilities. Upon the opening of the Magok institute, Samjin research institute will act as a connected collaboration and development center to lead open innovation through strategic alliance with highly competitive research institutes and bio/pharma companies in Korea and overseas, and will continuously expand its R&D infrastructure by the dedicated investment in R&D and large-scale recruitment of talented researchers. Samjin research institute will focus on the research for the human diseases with high unmet medical needs and develop the innovative new drugs and the novel platform technologies, leading Samjin Pharmaceutical's quantum jumps to become a global pharmaceutical company.